Issue 48, 2023

A two-step lighting DNA tetrahedral nanoprobe for precise imaging-guided photodynamic therapy of tumors

Abstract

Herein, we innovatively propose a mucin 1 and azoreductase dual-responsive DNA tetrahedral nanoprobe for two-step lighting imaging-guided photodynamic therapy of tumors. We hope that this highly specific, responsive and well biocompatible drug delivery system can be effectively used for the performance of cancer therapy in the hypoxia-related biomedical field.

Graphical abstract: A two-step lighting DNA tetrahedral nanoprobe for precise imaging-guided photodynamic therapy of tumors

Supplementary files

Article information

Article type
Communication
Submitted
24 Feb 2023
Accepted
25 Apr 2023
First published
04 May 2023

Chem. Commun., 2023,59, 7403-7406

A two-step lighting DNA tetrahedral nanoprobe for precise imaging-guided photodynamic therapy of tumors

F. Wu, Y. Li, L. Wang, C. Peng, Y. Zeng, J. Yang, H. Zhou and J. Zheng, Chem. Commun., 2023, 59, 7403 DOI: 10.1039/D3CC00883E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements